HeartBeam, Inc. (BEAT) |
| 0.4669 -0.019 (-3.85%) 08-28 16:00 |
| Open: | 0.4826 |
| High: | 0.4914 |
| Low: | 0.4602 |
| Volume: | 374,478 |
| Market Cap: | 26(M) |
| PE Ratio: | -0.92 |
| Exchange: | NASDAQ |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.63 |
| Resistance 1: | 0.56 |
| Pivot price: | 0.51 |
| Support 1: | 0.46 |
| Support 2: | 0.38 |
| 52w High: | 4 |
| 52w Low: | 0.46 |
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Financials
| EPS | -0.510 |
| Book Value | 0.010 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -153.5 |
| Return on Equity (ttm) | -328.4 |
Company news
Thu, 13 Aug 2026
HeartBeam, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BEAT) 2026-08-13 - Seeking Alpha
Thu, 13 Aug 2026
HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales - Stock Titan
Wed, 12 Aug 2026
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
Fri, 24 Jul 2026
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan
Wed, 01 Jul 2026
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule - Business Wire
Sat, 27 Jun 2026
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
